Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |